DSM boosts maternal and infant nutrition portfolio

Image credit- shutterstock.com

With new plant-based high potency DHA oil

Royal DSM, a purpose-led, global science-based company active in Nutrition, Health and Sustainable Living, announces the launch of its new, high-quality life’sDHA® SF55-O200DS oil for maternal and early life nutrition solutions. Offering a higher potency, this ingredient contains a minimum of 550 mg/g natural triglyceride DHA (docosahexaenoic acid), allowing manufacturers to achieve equivalent dosages of DHA in smaller product formats and meet the latest maternal nutrition trend for convenient capsule and tablet sizes.

This latest addition to DSM’s broad nutritional portfolio is the only 550 mg/g natural triglyceride DHA intended for use in maternal nutrition and is aimed for women who are planning to conceive, are pregnant, breastfeeding or non-breastfeeding post-natal mothers. Produced from Schizochytrium algae, life’sDHA SF55-O200DS offers a sustainable plant-based alternative to fish oil and is made with ingredients of conventional (non-GM) origin. A trusted source of contaminant-free, kosher and halal omega-3, life’sDHA SF55-O200DS supports infant health and development and can be consumed in a single, convenient dose.

“Convenience, quality and safety are key drivers of consumer purchasing in the maternal and early life nutrition markets, with mothers and expectant moms looking for easy-to-swallow dietary supplements and safe infant nutrition products made with trusted, science-backed ingredients, comments Brent MacDonald, Director Global Marketing & Business Development, Nutritional Lipids at DSM. “We carefully formulated life’sDHA SF55-O200DS to help manufacturers develop high-quality, reliable DHA solutions that will give pregnant women and moms peace of mind and that will shape healthier futures worldwide.”

Read Previous

Onelife Nutriscience expands executive team

Read Next

BLC introduces sweetolin to redefine confectionery

Leave a Reply